Program Description
Stroke remains a leading cause of death and disability worldwide, yet many cases are preventable through evidence-based interventions. The 2024 AHA/ASA guidelines for primary stroke prevention introduce significant updates, including a focus on addressing social determinants of health and new pharmacologic strategies like GLP-1 receptor agonists for high-risk patients. This activity equips pharmacists with the latest knowledge to identify and mitigate stroke risk factors, implement effective patient care plans, and enhance adherence to preventive strategies. By participating, pharmacists will gain actionable insights to support healthier outcomes in their communities.
Target audience: Ambulatory Care Pharmacist, Community Pharmacist
Type of activity: Application
Release date: June 9, 2025
Expiration date: June 9, 2026
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify key updates from the 2024 AHA/ASA guidelines for the primary prevention of stroke and their implications for community pharmacy practice.
- Explain the role of pharmacists in assessing and mitigating stroke risk factors through evidence-based lifestyle and pharmacologic interventions.
- Implement strategies to address social determinants of health and improve adherence to preventive measures among at-risk populations.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here